These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30172340)

  • 1. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
    Gordon LI
    Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
    [No Abstract]   [Full Text] [Related]  

  • 2. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
    Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
    Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
    Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
    Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
    Fowler NH
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
    [No Abstract]   [Full Text] [Related]  

  • 5. Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care.
    Dada R
    Acta Haematol; 2017; 138(4):216-220. PubMed ID: 29212067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
    Barr PM
    Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
    [No Abstract]   [Full Text] [Related]  

  • 7. Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study.
    Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):12; 14-5. PubMed ID: 24870876
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
    Messori A; Fadda V; Maratea D; Trippoli S
    Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
    Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
    Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
    Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
    Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
    [No Abstract]   [Full Text] [Related]  

  • 11. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
    Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does monocyte count have prognostic significance in cancer?
    Tadmor T
    Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
    Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
    Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.
    Sabater E; López-Guillermo A; Rueda A; Salar A; Oyagüez I; Collar JM
    Appl Health Econ Health Policy; 2016 Aug; 14(4):465-477. PubMed ID: 27090915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
    Nowakowski GS; LaPlant B; Habermann TM; Rivera CE; Macon WR; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Klebig RR; Reeder CB; Witzig TE
    Leukemia; 2011 Dec; 25(12):1877-81. PubMed ID: 21720383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment options have changed the survival of patients with follicular lymphoma.
    Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
    J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
    Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
    Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy].
    Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
    Tobinai K
    Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.
    de Mendonça GR; Brito AB; Rocha RM; Delamain MT; de Andrade Natal R; Soares FA; Colleoni GW; Souza CA; Vassallo J; Lima CS
    Blood Cancer J; 2016 Aug; 6(8):e464. PubMed ID: 27564462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.